Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Commentary

Reduce the likelihood of patient harm associated with the use of anticoagulant therapy: commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of Performance

Dager WE, Ansell J, Barnes GD, et al. “Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy”: Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of Performance. Jt Comm J Qual Saf. 2020;46(3):173-180. doi:10.1016/j.jcjq.2019.12.004.

Save
Print
March 4, 2020
Dager WE, Ansell J, Barnes GD, et al. Jt Comm J Qual Saf. 2020;46(3):173-180.
View more articles from the same authors.

The Joint Commission previously issued a sentinel event alert for medication errors relating to anticoagulant therapies and included them as part of the National Patient Safety Goal (NPSG) program. This commentary discusses the eight 2019 NPSGs for anticoagulants: dosing protocols; anticoagulant reversal; perioperative management; laboratory monitoring; anticoagulant safety; patient education; unit dose packaging, and; programmable pumps.  

Save
Print
Cite
Citation

Dager WE, Ansell J, Barnes GD, et al. “Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy”: Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of Performance. Jt Comm J Qual Saf. 2020;46(3):173-180. doi:10.1016/j.jcjq.2019.12.004.